A potential role for activated HER-2 in prostate cancer

被引：37
作者：
Agus, DB
Akita, RW
Fox, WD
Lofgren, JA
Higgins, B
Maiese, K
Scher, HI
Sliwkowski, MX
机构：
[1] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[3] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA
来源：
SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 06期
关键词：
D O I：
10.1053/sonc.2000.19890
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：76 / 83
页数：8
相关论文
共 53 条
[1]  
Agus DB, 1999, CANCER RES, V59, P4761
[2]   Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence [J].
Agus, DB ;
Cordon-Cardo, C ;
Fox, W ;
Drobnjak, M ;
Koff, A ;
Golde, DW ;
Scher, HI .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (21) :1869-1876
[3]   THE NEU ONCOGENE ENCODES AN EPIDERMAL GROWTH-FACTOR RECEPTOR-RELATED PROTEIN [J].
BARGMANN, CI ;
HUNG, MC ;
WEINBERG, RA .
NATURE, 1986, 319 (6050) :226-230
[4]  
CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303
[5]  
Carter P, 2000, Breast Dis, V11, P103
[6]   Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].
Clynes, RA ;
Towers, TL ;
Presta, LG ;
Ravetch, JV .
NATURE MEDICINE, 2000, 6 (04) :443-446
[7]   Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease [J].
Cobleigh, MA ;
Vogel, CL ;
Tripathy, D ;
Robert, NJ ;
Scholl, S ;
Fehrenbacher, L ;
Wolter, JM ;
Paton, V ;
Shak, S ;
Lieberman, G ;
Slamon, DJ .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2639-2648
[8]   A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase [J].
Craft, N ;
Shostak, Y ;
Carey, M ;
Sawyers, CL .
NATURE MEDICINE, 1999, 5 (03) :280-285
[9]   Growth factors in steroid-responsive prostatic tumor cells [J].
Dondi, D ;
Moretti, RM ;
Marelli, MM ;
Motta, M ;
Limonta, P .
STEROIDS, 1996, 61 (04) :222-225
[10]   DOWN-MODULATION OF AN ONCOGENE PROTEIN PRODUCT AND REVERSION OF THE TRANSFORMED PHENOTYPE BY MONOCLONAL-ANTIBODIES [J].
DREBIN, JA ;
LINK, VC ;
STERN, DF ;
WEINBERG, RA ;
GREENE, MI .
CELL, 1985, 41 (03) :695-706
123456